Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Cassidy

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Oxford Medical Case Reports|January 27, 2026
Asymptomatic central venous occlusion secondary to central venous catheter-use complicating pacemaker implantation: a leadless solutionJames Baudry, Christopher Cassidy, Kanarath Balachandran
Interactive Cardiovascular and Thoracic Surgery|December 29, 2021
Post-medistinoscopy chylopericardiumSherif Abbas, Manoj Purohit, Christopher Cassidy
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|September 22, 2020
Telemedicine during COVID-19: a survey of Health Care Professionals' perceptionsAbdula Elawady, Ahmed Khalil, Omar Assaf, et al.
JACC. Case Reports|July 28, 2021
Intermittent Loss of Telemetry Data: Lessons From a Leadless PacemakerDimitrios Katsaras, Christopher Cassidy, Mohammed Lakha, et al.
British Journal of Pharmacology|January 24, 2003
Pharmacological characterization of a 1,4-dihydropyridine analogue, 9-(3,4-dichlorophenyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydro-1,8(2H,5H)-acridinedione (A-184209) as a novelK(ATP) channel inhibitorMurali Gopalakrishnan, Thomas R Miller, Steven A Buckner, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractionsWilliam A Carroll, Robert J Altenbach, Hao Bai, et al.
Scientific Reports|January 4, 2023
Prevalence of pre-eclampsia and adverse pregnancy outcomes in women with pre-existing cardiomyopathy: a multi-centre retrospective cohort studyLaura Ormesher, Sarah Vause, Suzanne Higson, et al.
Circulation|April 25, 2026
Subcutaneous Defibrillator Implantation With or Without Defibrillation Test: The Primary Results of the Randomized PRAETORIAN-DFT TrialReinoud E Knops, Christelle Marquie, Peter Nordbeck, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Oxford Medical Case Reports|January 27, 2026
Asymptomatic central venous occlusion secondary to central venous catheter-use complicating pacemaker implantation: a leadless solutionJames Baudry, Christopher Cassidy, Kanarath Balachandran
Interactive Cardiovascular and Thoracic Surgery|December 29, 2021
Post-medistinoscopy chylopericardiumSherif Abbas, Manoj Purohit, Christopher Cassidy
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|September 22, 2020
Telemedicine during COVID-19: a survey of Health Care Professionals' perceptionsAbdula Elawady, Ahmed Khalil, Omar Assaf, et al.
JACC. Case Reports|July 28, 2021
Intermittent Loss of Telemetry Data: Lessons From a Leadless PacemakerDimitrios Katsaras, Christopher Cassidy, Mohammed Lakha, et al.
British Journal of Pharmacology|January 24, 2003
Pharmacological characterization of a 1,4-dihydropyridine analogue, 9-(3,4-dichlorophenyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydro-1,8(2H,5H)-acridinedione (A-184209) as a novelK(ATP) channel inhibitorMurali Gopalakrishnan, Thomas R Miller, Steven A Buckner, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractionsWilliam A Carroll, Robert J Altenbach, Hao Bai, et al.
Scientific Reports|January 4, 2023
Prevalence of pre-eclampsia and adverse pregnancy outcomes in women with pre-existing cardiomyopathy: a multi-centre retrospective cohort studyLaura Ormesher, Sarah Vause, Suzanne Higson, et al.
Circulation|April 25, 2026
Subcutaneous Defibrillator Implantation With or Without Defibrillation Test: The Primary Results of the Randomized PRAETORIAN-DFT TrialReinoud E Knops, Christelle Marquie, Peter Nordbeck, et al.
Pageof 1